Issued Patents 2020
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10875885 | β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment | Jean-Pierre Sommadossi | 2020-12-29 |
| 10874687 | Highly active compounds against COVID-19 | Jean-Pierre Sommadossi | 2020-12-29 |
| 10870672 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Jean-Pierre Sommadossi | 2020-12-22 |
| 10870673 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Jean-Pierre Sommadossi | 2020-12-22 |
| 10815266 | β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment | Jean-Pierre Sommadossi | 2020-10-27 |
| 10723754 | 2′,4′-bridged nucleosides for HCV infection | Benjamin Alexander Mayes, Alistair James Stewart | 2020-07-28 |
| 10717758 | D-amino acid compounds for liver disease | Benjamin Alexander Mayes, Alistair James Stewart, David Dukhan | 2020-07-21 |
| 10711029 | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection | Jean-Pierre Sommadossi | 2020-07-14 |
| 10683321 | 4′-or nucleosides for the treatment of HCV | David Dukhan, Cyril B. Dousson, Benjamin Alexander Mayes, Alistair James Stewart | 2020-06-16 |